Warren Foust - 14 Mar 2025 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
President and COO
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Warren Foust
Issuer symbol
STAA
Transactions as of
14 Mar 2025
Net transactions value
$0
Form type
4
Filing time
18 Mar 2025, 18:04:02 UTC
Previous filing
14 Mar 2025
Next filing
04 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Award $0 +58,651 $0.000000 58,651 14 Mar 2025 Common Stock 58,651 $0.000000 Direct F1, F2
transaction STAA Restricted Stock Units Award $0 +29,326 $0.000000 29,326 14 Mar 2025 Common Stock 29,326 $0.000000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2 Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (19,550 shares) on March 14, 2026, 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028.
F3 Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to President and Chief Operating Officer. These RSUs vest as to 1/3 (9,775 shares) on March 14, 2026, 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028.